Table 2.
General data of the study subjects.
| Index | Control group (n=24) | Intervention group (n=64) | p-value |
|---|---|---|---|
| Gender (Male/Female) | 23/1 | 52/12 | 0.32* |
| Age | 56 (29, 65) | 54 (29, 67) | 0.61** |
| BMI index | 24.97±4.10 | 24.08±4.02 | 0.34*** |
| Preoperative hospitalization days | 2 (1, 26) | 3 (1, 33) | 0.18** |
| MELD score | 22 (12, 35) | 20 (8, 40) | 0.27** |
| Primary liver cancer | 11 | 25 | – |
| Drug-induced liver injury | 0 | 2 | – |
| Decompensated hepatitis B cirrhosis | 5 | 18 | – |
| Decompensated hepatitis C cirrhosis | 0 | 3 | – |
| Decompensated alcoholic cirrhosis | 1 | 9 | – |
| Liver failure | 5 | 6 | – |
| Autoimmune liver disease | 2 | 1 | – |
| Cholestatic cirrhosis | 0 | 1 | – |
| Spontaneous bacterial peritonitis (SBP) | 0 | 0 | – |
| Receive antibiotics | 5 | 8 | 0.54* |
| Diabetes | 4 | 9 | 0.76* |
| Obesity | 2 | 3 | 0.67* |
| Kidney disease | 3 | 3 | 1.00* |
*
p-value calculated using chi-square test;
**
p-value calculated using Mann-Whitney U test;
***
p-value calculated using t-test.